These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism. Dai W, Xiang W, Han L, Yuan Z, Wang R, Ma Y, Yang Y, Cai S, Xu Y, Mo S, Li Q, Cai G. Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817 [Abstract] [Full Text] [Related]
5. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway. Yang X, Liu Q, Li Y, Tang Q, Wu T, Chen L, Pu S, Zhao Y, Zhang G, Huang C, Zhang J, Zhang Z, Huang Y, Zou M, Shi X, Jiang W, Wang R, He J. Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596 [Abstract] [Full Text] [Related]
19. Fatty acid synthesis is critical for stem cell pluripotency via promoting mitochondrial fission. Wang L, Zhang T, Wang L, Cai Y, Zhong X, He X, Hu L, Tian S, Wu M, Hui L, Zhang H, Gao P. EMBO J; 2017 May 15; 36(10):1330-1347. PubMed ID: 28377463 [Abstract] [Full Text] [Related]
20. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism. Dai W, Xu L, Yu X, Zhang G, Guo H, Liu H, Song G, Weng S, Dong L, Zhu J, Liu T, Guo C, Shen X. J Hepatol; 2020 May 15; 72(5):909-923. PubMed ID: 31899205 [Abstract] [Full Text] [Related] Page: [Next] [New Search]